Global Cell And Gene Therapy Manufacturing Market By Therapy Type (Cell therapy, Gene therapy) By Mode (In-house Manufacturing, Contract Manufacturing (CDMOs & CMOs)) By Scale (Preclinical and Clinical-Scale, Commercial-Scale) By Application (Oncology (Cancer Treatment), Neurological Disorders, Cardiovascular Diseases, Rare & Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Autoimmune Diseases, Other Applications) By End-user (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations (CDMOs/CMOs), Research Institutes & Academic Organizations, Hospitals & Clinics) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2025-2034
- Published date: April 2025
- Report ID: 146488
- Number of Pages: 394
- Format:
-
-
-
- Lonza Group AG Company Profile
- Bluebird Bio Inc.
- Catalent Inc.
- F. Hoffmann-La Roche Ltd.
- Samsung Biologics
- Boehringer Ingelheim
- Cellular Therapeutics
- Hitachi Chemical Co., Ltd.
- Takara Bio Inc.
- Miltenyi Biotec
- Thermo Fisher Scientific Company Profile
- F. Hoffmann-La Roche Ltd
- Novartis AG Company Profile
- Merck KGaA Company Profile
- Others
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible